A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe

CONCLUSIONS: The study showed long-lasting effects after 25I-NBOMe administration and allowed for the determination of HPPD risk factors.PMID:34980551 | DOI:10.1016/j.biopha.2021.112295

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - January 4, 2022 Category: Drugs & Pharmacology Authors: Daria Schetz Adriana Schetz Ivan Koci ć Source Type: research